All Type of News
Both ruling & opposition parties to support ‘opposition to remote drug dispensers’
Representatives of the ruling and opposition parties, who participated in the National Pharmaceutical Convention, showed opposing opinions to implementation of video drug dispensers, which created enthusiastic respons...
Multinational pharmas’ OTC drugs averagely have 10% profit rate in pharmacies
Pharmacies’ profits on selling well-known OTC drugs manufactured and distributed by multinational pharmaceutical companies are still observed to stay low.
According to the result of comparing well-known 6 OTC drugs’ ...
Leading products shifting generations, ‘Sovaldi’ & ‘Daklinza’
The Korean outpatient prescription market is experiencing a shift in generations. Raising positions in the ranking, Gilead Sciences’ hepatitis C treatment ‘Sovaldi’ and BMS’s ‘Daklinza’ have taken the leading roles in...
Forxiga smile with first PMS result conducted on large Koreans
The post-marketing surveillance(PMS) result of ‘Forxiga(generic name: dapagliflozin),’ a SGLT-2 inhibitor whose research was conducted on 1,500 Korean diabetes type 2 patients, has been released. The 24-week researche...
Rapid progress on implementation of medical checkup for hepatitis C, triggered by Dana Clinic incident
Implementation of medical checkup for hepatitis C has reportedly be proceeded rapidly due to political issues, such as the Dana Clinic’s mass infection incident.
Finance Director Ji-Hoon Kim(Gastroenterology Professo...
7.7 Reform Measure for Insurance Price to be confirmed
The preferential policy on biomedicine and innovative drug prices and the drug price cuts on market prices are expected to be finalized and implemented.
At the announcement of the 10th Trade-Investment Promotion Meet...
“CKD and Hanmi had smile in outpatient prescription market”In this 3rd quarter’s outpatient prescription market, it was observed there was fierce competition among pharmaceutical companies.
In the top group, Chong Kun Dang(CKD) and Ha...
|
LG-UNICEF supply agreement of ‘Eupenta’ worth of KRW 91.7 billionOn the 20th, LG Sciences it signed a supply agreement(2017-2019, orders from regular bidding) of its pentavalent vaccine ‘Eupenta’ with ‘UNICEF Supply Division’ on the 19th.
I...
|
Celltrion’s Remsima presented clinical study result led by Norwegian governmentA result of the long-term clinical trial to research the Remsima’s substitute administration, ‘NOR-SWITCH Study’ was released at the United European Gastroenterology Week(UEGW) ...
|
Celltrion’s ‘Remsima’ exceeded KRW 1 trillion collective exportsOn the 19th, Celltrion announced the collective exports of its affiliate, Celltrion Healthcare, exceeded KRW 1 trillion. Celltrion Healthcare is an affiliate taking charge in ov...
|
